108 related articles for article (PubMed ID: 2750703)
1. Myelodysplasia and acute leukemia following treatment for Hodgkin's disease.
McKenna RW; Brunning RD
Am J Clin Pathol; 1989 Jul; 92(1):127-8. PubMed ID: 2750703
[No Abstract] [Full Text] [Related]
2. Myelodysplasia with bone marrow lymphocytosis and fibrosis mimicking recurrent Hodgkin's disease.
Gottlieb CA; Maeda K; Hawley RC; Abraham JP
Am J Clin Pathol; 1989 Jan; 91(1):6-11. PubMed ID: 2910015
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia with myelodysplasia-related changes showing basophilic differentiation.
Wells R; Williams B; Bain BJ
Am J Hematol; 2014 Nov; 89(11):1082. PubMed ID: 24941894
[No Abstract] [Full Text] [Related]
4. [Myelodysplasia--a newly defined preliminary stage of acute leukemia].
Hunstein W; Ho AD
Verh Dtsch Ges Inn Med; 1986; 92():85-9. PubMed ID: 3468691
[No Abstract] [Full Text] [Related]
5. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
7. [CME myelodysplasia - a frequent hematologic neoplasia in the elderly].
Schleiffenbaum BE
Praxis (Bern 1994); 2014 May; 103(11):617-27. PubMed ID: 24846886
[No Abstract] [Full Text] [Related]
8. [Coexistence of Hodgkin's disease and myelodysplastic syndrome with late conversion to acute myeloblastic leukemia].
Woźny T
Wiad Lek; 1989 Feb; 42(3):170-2. PubMed ID: 2623860
[TBL] [Abstract][Full Text] [Related]
9. Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia.
Polychronopoulou S; Panagiotou JP; Papadakis T; Mavrou A; Anagnostou D; Haidas S
Med Pediatr Oncol; 1996 May; 26(5):359-66. PubMed ID: 8614370
[TBL] [Abstract][Full Text] [Related]
10. Myelomonocytic leukemia in Hodgkin's disease.
Newman DR; Maldonado JE; Harrison EG; Kiely JM; Linman JW
Cancer; 1970 Jan; 25(1):128-34. PubMed ID: 5262258
[No Abstract] [Full Text] [Related]
11. Significance of bone marrow sideroblastosis in myelodysplastic syndromes.
Economopoulos T; Karakassis D; Stathakis N; Pappa V; Raptis S
Eur J Haematol; 1990 Aug; 45(2):118-20. PubMed ID: 2209817
[No Abstract] [Full Text] [Related]
12. Myelodysplastic syndromes: preleukemic or early leukemic conditions?
Dörmer P
Haematol Blood Transfus; 1990; 33():3-7. PubMed ID: 2323634
[No Abstract] [Full Text] [Related]
13. Hodgkin's disease and leukemia.
Chan BW; McBride JA
Can Med Assoc J; 1972 Mar; 106(5):558-61. PubMed ID: 4503267
[TBL] [Abstract][Full Text] [Related]
14. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
15. Prognostic factors in the myelodysplastic syndromes: a review.
Tricot G; Vlietinck R; Verwilghen RL
Scand J Haematol Suppl; 1986; 45():107-13. PubMed ID: 3515514
[No Abstract] [Full Text] [Related]
16. Histopathology in the diagnosis of high-risk myelodysplastic syndromes.
Kayano H
J Clin Exp Hematop; 2018; 58(2):51-60. PubMed ID: 29998976
[TBL] [Abstract][Full Text] [Related]
17. [Myelodysplastic syndrome--its natural history, clinical course and diagnosis].
Weryńska B
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):867-71. PubMed ID: 2487939
[No Abstract] [Full Text] [Related]
18. Sinusoidal endothelial cells are damaged and display enhanced autophagy in myelodysplastic syndromes.
Houwerzijl EJ; van den Heuvel FA; Blom NR; van der Want JJ; Mulder AB; Vellenga E
Br J Haematol; 2013 May; 161(3):443-6. PubMed ID: 23360384
[No Abstract] [Full Text] [Related]
19. Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Lipshultz SE; Lipsitz SR; Orav EJ
J Clin Oncol; 2007 Jul; 25(21):3179; author reply 3180. PubMed ID: 17634500
[No Abstract] [Full Text] [Related]
20. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
